A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

National Taiwan University Hospital /ID# 163997, Taipei

Blacktown Hospital /ID# 167386, Blacktown

Universitair Ziekenhuis Antwerpen /ID# 170702, Edegem

St Vincent's Hospital Melbourne /ID# 167552, Fitzroy Melbourne

Linear Clinical Research /ID# 170797, Nedlands

Medizinische Universitaet Graz /ID# 168752, Graz

UZ Gent /ID# 170881, Ghent

Taipei Medical University Hospital /ID# 163998, Taipei

Virginia Cancer Specialists - Fairfax /ID# 157377, Fairfax

Hospital Universitario Fundacion Jimenez Diaz /ID# 163862, Madrid

Hospital Universitario HM Sanchinarro /ID# 163861, Madrid

Carolina BioOncology Institute /ID# 157376, Huntersville

Institut Bergonie /ID# 162662, Bordeaux

Tampere University Hospital /ID# 166839, Tampere

Institut du Cancer de Montpellier - Val d'Aurelle /ID# 163999, Montpellier

Hospital Clinico Universitario de Valencia /ID# 163925, Valencia

Centre Leon Berard /ID# 162660, Lyon

South Texas Accelerated Research Therapeutics /ID# 157378, San Antonio

Moores Cancer Center at UC San Diego /ID# 157374, La Jolla

Institut Gustave Roussy /ID# 162753, Villejuif

The University of Chicago Medical Center /ID# 157375, Chicago

Cross Cancer Institute /ID# 167603, Edmonton

Docrates Cancer Center /ID# 166838, Helsinki

National Cancer Center Hospital East /ID# 166433, Kashiwa-shi

National Hospital Organization Kyushu Cancer Center /ID# 206229, Fukuoka

National Cancer Center Hospital /ID# 166279, Chuo-ku